Global Paclitaxel Injection Market Insights, Forecast to 2025


Report ID : RC-3017 Category : Healthcare Published Date : 2018
Publisher : QYResearch Pages : 110 Format : PDF
This report studies the global market size of Paclitaxel Injection in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Paclitaxel Injection in these regions.
This research report categorizes the global Paclitaxel Injection market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What’s more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

In 2017, the global Paclitaxel Injection market size was 2180 million US$ and is forecast to 4560 million US in 2025, growing at a CAGR of 11.1% from 2018. The objectives of this study are to define, segment, and project the size of the Paclitaxel Injection market based on company, product type, application and key regions.

The various contributors involved in the value chain of Paclitaxel Injection include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Paclitaxel Injection include

    Bristol-Myers Squibb

    Celgene Corporation

    Hospira

    Biological E.

    Taj Accura

    Khandelwal Laboratories

    Luye Pharma

    Beijing Youcare

    Beijing Union

    Haiyao

    Chuntch

Market Size Split by Type

    Drug Strength

    Raw meterial Paclitaxel API source

Market Size Split by Application

    Ovarian cancer

    Breast cancer

    Cervical cancer

    Pancreatic cancer

    Other

Market size split by Region

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

The study objectives of this report are:

    To study and analyze the global Paclitaxel Injection market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Paclitaxel Injection market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Paclitaxel Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Paclitaxel Injection with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Paclitaxel Injection submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Paclitaxel Injection are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Paclitaxel Injection market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage

1.1 Paclitaxel Injection Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Paclitaxel Injection Market Size Growth Rate by Type

1.4.2 Drug Strength

1.4.3 Raw meterial Paclitaxel API source

1.5 Market by Application

1.5.1 Global Paclitaxel Injection Market Size Growth Rate by Application

1.5.2 Ovarian cancer

1.5.3 Breast cancer

1.5.4 Cervical cancer

1.5.5 Pancreatic cancer

1.5.6 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Paclitaxel Injection Market Size

2.1.1 Global Paclitaxel Injection Revenue 2016-2025

2.1.2 Global Paclitaxel Injection Sales 2016-2025

2.2 Paclitaxel Injection Growth Rate by Regions

2.2.1 Global Paclitaxel Injection Sales by Regions

2.2.2 Global Paclitaxel Injection Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Paclitaxel Injection Sales by Manufacturers

3.1.1 Paclitaxel Injection Sales by Manufacturers

3.1.2 Paclitaxel Injection Sales Market Share by Manufacturers

3.1.3 Global Paclitaxel Injection Market Concentration Ratio (CR5 and HHI)

3.2 Paclitaxel Injection Revenue by Manufacturers

3.2.1 Paclitaxel Injection Revenue by Manufacturers (2016-2018)

3.2.2 Paclitaxel Injection Revenue Share by Manufacturers (2016-2018)

3.3 Paclitaxel Injection Price by Manufacturers

3.4 Paclitaxel Injection Manufacturing Base Distribution, Product Types

3.4.1 Paclitaxel Injection Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Paclitaxel Injection Product Category

3.4.3 Date of International Manufacturers Enter into Paclitaxel Injection Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Paclitaxel Injection Sales by Type

4.2 Global Paclitaxel Injection Revenue by Type

4.3 Paclitaxel Injection Price by Type

5 Breakdown Data by Application

5.1 Overview

5.2 Global Paclitaxel Injection Breakdown Data by Application

6 North America

6.1 North America Paclitaxel Injection by Countries

6.1.1 North America Paclitaxel Injection Sales by Countries

6.1.2 North America Paclitaxel Injection Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Paclitaxel Injection by Type

6.3 North America Paclitaxel Injection by Application

6.4 North America Paclitaxel Injection by Company

7 Europe

7.1 Europe Paclitaxel Injection by Countries

7.1.1 Europe Paclitaxel Injection Sales by Countries

7.1.2 Europe Paclitaxel Injection Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Paclitaxel Injection by Type

7.3 Europe Paclitaxel Injection by Application

7.4 Europe Paclitaxel Injection by Company

8 Asia Pacific

8.1 Asia Pacific Paclitaxel Injection by Countries

8.1.1 Asia Pacific Paclitaxel Injection Sales by Countries

8.1.2 Asia Pacific Paclitaxel Injection Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Paclitaxel Injection by Type

8.3 Asia Pacific Paclitaxel Injection by Application

8.4 Asia Pacific Paclitaxel Injection by Company

9 Central & South America

9.1 Central & South America Paclitaxel Injection by Countries

9.1.1 Central & South America Paclitaxel Injection Sales by Countries

9.1.2 Central & South America Paclitaxel Injection Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Paclitaxel Injection by Type

9.3 Central & South America Paclitaxel Injection by Application

9.4 Central & South America Paclitaxel Injection by Company

10 Middle East and Africa

10.1 Middle East and Africa Paclitaxel Injection by Countries

10.1.1 Middle East and Africa Paclitaxel Injection Sales by Countries

10.1.2 Middle East and Africa Paclitaxel Injection Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Paclitaxel Injection by Type

10.3 Middle East and Africa Paclitaxel Injection by Application

10.4 Middle East and Africa Paclitaxel Injection by Company

11 Company Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Details

11.1.2 Company Description

11.1.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.1.4 Paclitaxel Injection Product Description

11.1.5 Recent Development

11.2 Celgene Corporation

11.2.1 Celgene Corporation Company Details

11.2.2 Company Description

11.2.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.2.4 Paclitaxel Injection Product Description

11.2.5 Recent Development

11.3 Hospira

11.3.1 Hospira Company Details

11.3.2 Company Description

11.3.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.3.4 Paclitaxel Injection Product Description

11.3.5 Recent Development

11.4 Biological E.

11.4.1 Biological E. Company Details

11.4.2 Company Description

11.4.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.4.4 Paclitaxel Injection Product Description

11.4.5 Recent Development

11.5 Taj Accura

11.5.1 Taj Accura Company Details

11.5.2 Company Description

11.5.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.5.4 Paclitaxel Injection Product Description

11.5.5 Recent Development

11.6 Khandelwal Laboratories

11.6.1 Khandelwal Laboratories Company Details

11.6.2 Company Description

11.6.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.6.4 Paclitaxel Injection Product Description

11.6.5 Recent Development

11.7 Luye Pharma

11.7.1 Luye Pharma Company Details

11.7.2 Company Description

11.7.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.7.4 Paclitaxel Injection Product Description

11.7.5 Recent Development

11.8 Beijing Youcare

11.8.1 Beijing Youcare Company Details

11.8.2 Company Description

11.8.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.8.4 Paclitaxel Injection Product Description

11.8.5 Recent Development

11.9 Beijing Union

11.9.1 Beijing Union Company Details

11.9.2 Company Description

11.9.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.9.4 Paclitaxel Injection Product Description

11.9.5 Recent Development

11.10 Haiyao

11.10.1 Haiyao Company Details

11.10.2 Company Description

11.10.3 Sales, Revenue and Gross Margin of Paclitaxel Injection

11.10.4 Paclitaxel Injection Product Description

11.10.5 Recent Development

11.11 Chuntch

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

12.1 Market Opportunities and Drivers

12.2 Market Challenges

12.3 Market Risks/Restraints

12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

13.1 Value Chain Analysis

13.1.1 Typical Suppliers of Key Paclitaxel Injection Raw Material

13.1.2 Paclitaxel Injection Customers

13.2 Sales Channels Analysis

13.2.1 Sales Channels Analysis

13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

15.3 Disclaimer



Sidebar Menu